BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• 

  Sponsored

  SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological

  Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.

  July 15, 2024

   · 

  3 min read
• 

  Opinion

  Congress Must Reauthorize FDA Program for Pediatric Rare Diseases

  Why I advocated on Capitol Hill this month for the renewal of the FDA’s Priority Review Voucher program

  July 15, 2024

   · 

  6 min read

   · 

  Matthew Winton
• 

  Neuroscience

  5 Neuro Data Readouts to Watch in the Second Half of 2024

  After a busy first half of 2024, several companies are expecting key data readouts in the neuropsychiatric and neurodegenerative disease spaces during the next six months.

  July 15, 2024

   · 

  6 min read

   · 

  Heather McKenzie
• 

  IPO

  Metagenomi CSO Steps Down Shortly After IPO, Moderna Exit

  Following a disappointing IPO and the loss of Moderna’s gene editing contract, Metagenomi’s Chief Scientific Officer Luis Borges is departing the biotech.

  July 15, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Friedreich’s ataxia

  Lexeo’s Gene Therapy Shows Early Promise for Friedreich’s Ataxia Cardiomyopathy

  Lexeo Therapeutics’ investigational gene therapy reduces left ventricular volume and wall thickness in patients with Friedreich’s ataxia, according to a small study.

  July 15, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Neuropsychiatric disorders

  Ozempic Tied to Lower Risk of Dementia, Nicotine Misuse: Study

  Despite recent concerns about suicidality and other neuropsychiatric issues, a recent study has found that Novo Nordisk’s Ozempic (semaglutide) is associated with lower risks of dementia, cognitive deficit and nicotine misuse.

  July 15, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Parkinson’s disease

  Breaking the Cycle of Inflammation in Parkinson’s Disease

  Halia Therapeutics, NodThera and Gain Therapeutics target neuroinflammatory processes in hopes of modifying the course of Parkinson’s progression.

  July 15, 2024

   · 

  4 min read

   · 

  Jill Drachenberg
• Press Releases

  Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform

  July 15, 2024

   · 

  5 min read
• Press Releases

  Rectify Pharmaceuticals Appoints Bharat Reddy as Chief Business Officer

  July 15, 2024

   · 

  2 min read
• 

  Press Releases

  Alzheimer’s Disease Market to Reach USD 6.3 Billion by 2034, Impelled by Advancements in Diagnostic Techniques

  July 15, 2024

   · 

  9 min read